NCT06682871

Brief Summary

İntroduction The World Health Organisation (WHO) and United Nations Children's Fund (UNICEF) recommends that infants are exclusively breastfed for a minimum of 6 months, with continued breastfeeding recommended until child age of 2 years or over to optimize growth, development, and health. Breast milk shows significant benefits for the physical and mental health of mothers and infants, including the promotion of maternal and infant bonding, the reduction of neonatal mortality, the reduction of maternal postoperative complications, and the development of newborns. Breastfeeding has been associated with improved maternal/infant bonding and increased child intelligence. It is also clear that medical interventions during labor and birth, including a caesarean section, impact on women's infant feeding decisions and are a cause for concern given increasing global caesarean birth rates, with woman who have a planned caesarean birth reported as less likely to intend to breastfeed than women who did not have a planned caesarean birth or had a vaginal birth. Infrequent feeding and women's limited mobility in the early days following surgery may impede efforts to provide basic infant care. High levels of postoperative pain, particularly in the first 24 hrs, were also found to have a negative impact on women's breastfeeding experiences. Cesarean delivery is linked with lower rates of early breastfeeding initiation. Pain management after casarean delivery remains challenging. The best-accepted traditional analgesic approach is continuous epidural analgesia. However, epidural analgesia is rapidly being replaced by transversus abdominis plane (TAP) blocks. TAP infiltration is an alternative to epidural blocks for providing postoperative analgesia to the anterior abdominal wall. TAP infiltrations are relatively easy to perform, generally safe, and can be performed in patients who are anti-coagulated. TAP infiltration can be performed as a single injection, or a catheter can be inserted for continuous local anesthetic infusion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 21, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

November 12, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 23, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2025

Completed
Last Updated

September 3, 2025

Status Verified

September 1, 2025

Enrollment Period

1.6 years

First QC Date

October 21, 2024

Last Update Submit

September 2, 2025

Conditions

Keywords

Post-cesarean analgesiaBreastfeedinglatch scorevisuel pain score

Outcome Measures

Primary Outcomes (1)

  • To compare the effect of pain management after cesarean on the rates of initiation of breastfeeding

    Four quadrant TAP blocks performed after elective inert cesarean section increase the rate of breastfeeding in the first 1 hour and the rate of exclusive breastfeeding in the first 72 hours.

    1 year

Study Arms (3)

Arm T: Transversus Abdominis Plane (TAP) blocks with bupivacaine

ACTIVE COMPARATOR

Infants of mothers who received 4-Quadrant TAP block after inactive elective spinal cesarean section (25 patients)

Procedure: Analgesia

Arm E : Epidural Analgesia with bupivacaine

ACTIVE COMPARATOR

Infants of mothers who received Epidural analgesia after inactive elective spinal cesarean section (25 patients)

Procedure: Analgesia

Arm M: Iv Multimodal Analgesia with paracetamol or tramadol

ACTIVE COMPARATOR

Infants of mothers who received Multimodal intravenous analgesia after inactive elective spinal cesarean section (25 patients)

Procedure: Analgesia

Interventions

AnalgesiaPROCEDURE

Postoperatively, patients will be given analgesia

Arm E : Epidural Analgesia with bupivacaineArm M: Iv Multimodal Analgesia with paracetamol or tramadolArm T: Transversus Abdominis Plane (TAP) blocks with bupivacaine

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Written informed consent;
  • years old;
  • ASA Physical Status 1-3;
  • Scheduled for elective cesarien delivery;
  • Anticipated hospitalization of at least three nights;
  • Expected requirement for parenteral opioids for at least 72 hours for postoperative pain;
  • Able to use IV PCA systems.

You may not qualify if:

  • Hepatic disease, e.g. twice the normal levels of liver enzymes;
  • Kidney disease, e.g. twice the normal level of serum creatinine;
  • Bupivacaine sensitivity or known allergy;
  • Anticoagulants considered to be a contraindication for TAP blocks;
  • Surgeries with high port sites

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Konya City Hospital

Konya, 42080, Turkey (Türkiye)

Location

Related Publications (1)

  • MacGregor E, Hughes M. Breastfeeding experiences of mothers from disadvantaged groups: a review. Community Pract. 2010 Jul;83(7):30-3.

Related Links

MeSH Terms

Conditions

Breast FeedingAgnosia

Interventions

Analgesia

Condition Hierarchy (Ancestors)

Feeding BehaviorBehaviorPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anesthesia and Analgesia

Study Officials

  • Ramazan Keçeci, Specialist

    Konya City Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Randomization will be based on computer-generated codes and use random-sized blocks. Allocations will be concealed until the morning of surgery where they will be provided by a web-based system
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: D. Protocol After eligibility is confirmed, patients will receive complete information about the study both verbally and in writing. Informed consent will be obtained from the patients prior to randomization and study-specific procedures. Randomization will be based on computer-generated codes and use random-sized blocks. Allocations will be concealed until the morning of surgery where they will be provided by a web-based system.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
NEONATOLOGIST, MD, PRINCIPAL INVESTIGATOR

Study Record Dates

First Submitted

October 21, 2024

First Posted

November 12, 2024

Study Start

January 1, 2024

Primary Completion

July 23, 2025

Study Completion

July 25, 2025

Last Updated

September 3, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

The protocol can be shared once the study is completed

Shared Documents
STUDY PROTOCOL
Time Frame
1 year
Access Criteria
No Criteria
More information

Locations